Advancing MP1, a novel depolymerase for perpetual cradle-to-cradle plastics recycling
推进 MP1,一种用于永久塑料回收的新型解聚酶
基本信息
- 批准号:10004704
- 负责人:
- 金额:$ 38.49万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Collaborative R&D
- 财政年份:2021
- 资助国家:英国
- 起止时间:2021 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
**PROBLEM**Plastic packaging, and in particular plastic film, can pose significant challenges to recyclers. It is a major problem as it is often co-laminated, containing additives, and contaminated. It can also damage sorting machinery.The widespread collection and reprocessing of plastic film in the UK (and in most developed countries) is limited; just 10% of local authorities in the UK accept all types of plastic film for recycling, thus it frequently reaches landfill.In the UK, 1.2 million tonnes of plastic film were used in 2017\. Based on current collection rates, this suggests that significant amounts of plastic film reach landfill each year in the UK.**OPPORTUNITY**Mellizyme have identified a novel enzyme 'MP1' that can degrade certain bonds within plastics commonly used in plastic films to liberate small molecules.Standard physico-chemical recycling methods leads to loss of plastic quality between recycling rounds. When degraded beyond re-use, this the creates waste for incineration (generating CO2) or landfill (which can leach chemicals into the environment).This is problem is overcome by MP1, as the biological degradation of the plastic film polymers maintains integrity of the small molecules liberated. This supports perpetual cradle-to-cradle recycling.There is significant market opportunity for MP1; globally, just 9% of the 7.82Bn tons of plastic produced in 2015 was recycled, suggestive of a significant opportunity for recyclers to valorise plastics that would be otherwise destined for landfill or incineration.**KEY PROJECT OBJECTIVES**Maturation of Mellizyme technology from TRL3 to TRL5\. The project outputs are critical for subsequent industrial-scale demonstration.**INNOVATIONS**Current state-of-the-art approaches:* Multilayer plastic films can be deconstructed, but this requires energy and chemical-intensive solvent-targeted recovery and precipitation.* Several microbes can degrade some plastics, but this appears to be only of low molecular weight components, rather than the long-chain polymer backbones.* An enzyme isolated from a tree has demonstrated activity against plastic resins, but the reaction mixture requires triazole supplementation.MP1 improvements over this state-of-the-art:* MP1 has activity across many plastic types within different 'families' of plastics.* MP1 does not require any harsh chemical solvents to be used as adjuvants to the reaction.* MP1-type enzymes are fast, with turnover numbers \>1000^s-1 (for comparison, the best enzyme that degrades the ester PET has a turnover number of just 1.2^s-1).
** 问题 ** 塑料包装,特别是塑料薄膜,可能对回收商构成重大挑战。这是一个主要的问题,因为它往往是共同层压,含有添加剂,和污染。在英国(以及大多数发达国家),塑料薄膜的广泛收集和再处理是有限的;英国只有10%的地方当局接受所有类型的塑料薄膜进行回收,因此它经常进入垃圾填埋场。在英国,2017年使用了120万吨塑料薄膜。根据目前的收集率,这表明英国每年有大量的塑料薄膜进入垃圾填埋场。机会 ** 美力酶发现了一种新型酶“MP 1”,它可以降解塑料薄膜中常用的塑料中的某些键,释放出小分子。标准的物理化学回收方法会导致塑料质量在回收轮次之间损失。当降解到无法再利用时,会产生用于焚烧(产生CO2)或填埋(可将化学品沥滤到环境中)的废物。MP 1解决了这个问题,因为塑料薄膜聚合物的生物降解保持了释放的小分子的完整性。MP 1有着巨大的市场机会; 2015年全球生产的78.2亿吨塑料中只有9%被回收,这表明回收商有很大的机会来提高塑料的价值,否则这些塑料将被填埋或焚烧。** ** Mellizyme技术从TRL 3成熟到TRL 5\。项目产出对随后的工业规模示范至关重要。** 目前最先进的方法:* 多层塑料薄膜可以被分解,但这需要能源和化学密集型的溶剂目标回收和沉淀。*几种微生物可以降解一些塑料,但这似乎只是低分子量组分,而不是长链聚合物主链。从树中分离的一种酶已被证明对塑料树脂具有活性,但反应混合物需要三唑消除。MP 1在这一最新技术水平上的改进:* MP 1对不同“家族”塑料中的许多塑料类型都具有活性。* MP 1不需要使用任何苛刻的化学溶剂作为反应助剂。* MP 1型酶的速度很快,其周转数> 1000 ^s-1(相比之下,降解酯PET的最佳酶的周转数仅为1.2 ^s-1)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
其他文献
吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('', 18)}}的其他基金
An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
- 批准号:
2901954 - 财政年份:2028
- 资助金额:
$ 38.49万 - 项目类别:
Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
- 批准号:
2896097 - 财政年份:2027
- 资助金额:
$ 38.49万 - 项目类别:
Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
- 批准号:
2780268 - 财政年份:2027
- 资助金额:
$ 38.49万 - 项目类别:
Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
- 批准号:
2908918 - 财政年份:2027
- 资助金额:
$ 38.49万 - 项目类别:
Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
- 批准号:
2908693 - 财政年份:2027
- 资助金额:
$ 38.49万 - 项目类别:
Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
- 批准号:
2908917 - 财政年份:2027
- 资助金额:
$ 38.49万 - 项目类别:
Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
- 批准号:
2879438 - 财政年份:2027
- 资助金额:
$ 38.49万 - 项目类别:
Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
- 批准号:
2890513 - 财政年份:2027
- 资助金额:
$ 38.49万 - 项目类别:
Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
- 批准号:
2879865 - 财政年份:2027
- 资助金额:
$ 38.49万 - 项目类别:
Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
- 批准号:
2876993 - 财政年份:2027
- 资助金额:
$ 38.49万 - 项目类别:
Studentship
相似海外基金
MP1: a novel enzyme for bio-manufacturing Adipic Acid
MP1:一种用于生物制造己二酸的新型酶
- 批准号:
10016171 - 财政年份:2022
- 资助金额:
$ 38.49万 - 项目类别:
Collaborative R&D
Modeling in vivo Protein-DNA Interactions from High-Throughput Data MP1/1
根据高通量数据 MP1/1 体内蛋白质-DNA 相互作用建模
- 批准号:
7911149 - 财政年份:2009
- 资助金额:
$ 38.49万 - 项目类别:
Modeling in vivo Protein-DNA Interactions from High-Throughput Data MP1/1
根据高通量数据 MP1/1 体内蛋白质-DNA 相互作用建模
- 批准号:
7918759 - 财政年份:2007
- 资助金额:
$ 38.49万 - 项目类别:
Modeling in vivo Protein-DNA Interactions from High-Throughput Data MP1/1
根据高通量数据 MP1/1 体内蛋白质-DNA 相互作用建模
- 批准号:
8137917 - 财政年份:2007
- 资助金额:
$ 38.49万 - 项目类别:
Modeling in vivo Protein-DNA Interactions from High-Throughput Data MP1/1
根据高通量数据 MP1/1 体内蛋白质-DNA 相互作用建模
- 批准号:
7302143 - 财政年份:2007
- 资助金额:
$ 38.49万 - 项目类别:
Modeling in vivo Protein-DNA Interactions from High-Throughput Data MP1/1
根据高通量数据 MP1/1 体内蛋白质-DNA 相互作用建模
- 批准号:
7685509 - 财政年份:2007
- 资助金额:
$ 38.49万 - 项目类别:
c-mp1を介する巨核球の増殖・分化の分子機構に関する研究
c-mp1介导巨核细胞增殖和分化的分子机制研究
- 批准号:
11162216 - 财政年份:1999
- 资助金额:
$ 38.49万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas (A)